| RBS | Name: | N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE | Formula: | C17 H14 N4 O | SMILES: | O=C(/C=C)Nc3cc1c(ncnc1Nc2ccccc2)cc3 | InChi: | InChI=1S/C17H14N4O/c1-2-16(22)20-13-8-9-15-14(10-13)17(19-11-18-15)21-12-6-4-3-5-7-12/h2-11H,1H2,(H,20,22)(H,18,19,21) | Definition date: | 2006-08-02 | Last modified: | 2024-09-27 | Identifier: | N-[4-(phenylamino)quinazolin-6-yl]prop-2-enamide |
|
| MF2 | Name: | CIS-2,6-DIMETHYLMORPHOLINOOCTYLCARBAMYLESEROLINE | Formula: | C15 H30 N2 O2 | SMILES: | O=CNCCCCCCCCN1CC(OC(C)C1)C | InChi: | InChI=1S/C15H30N2O2/c1-14-11-17(12-15(2)19-14)10-8-6-4-3-5-7-9-16-13-18/h13-15H,3-12H2,1-2H3,(H,16,18)/t14-,15+ | Synonyms: | MF268 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | N-{8-[(2R,6S)-2,6-dimethylmorpholin-4-yl]octyl}formamide |
|
| N86 | Name: | ~{N}-quinolin-7-ylprop-2-enamide | Formula: | C12 H10 N2 O | SMILES: | C=CC(=O)Nc1ccc2cccnc2c1 | InChi: | InChI=1S/C12H10N2O/c1-2-12(15)14-10-6-5-9-4-3-7-13-11(9)8-10/h2-8H,1H2,(H,14,15) | Definition date: | 2023-01-11 | Last modified: | 2024-09-27 | Release date: | 2023-12-13 | Identifier: | ~{N}-quinolin-7-ylprop-2-enamide |
|
| TSL | Name: | TRANS-ENAMINE INTERMEDIATE OF SULBACTAM | Formula: | C8 H13 N O5 S | SMILES: | O=S(O)C(C(NC=CC=O)C(=O)O)(C)C | InChi: | InChI=1S/C8H13NO5S/c1-8(2,15(13)14)6(7(11)12)9-4-3-5-10/h3-6,9H,1-2H3,(H,11,12)(H,13,14)/b4-3+/t6-/m0/s1 | Definition date: | 2005-07-28 | Last modified: | 2024-09-27 | Identifier: | N-[(1E)-3-oxoprop-1-en-1-yl]-3-sulfino-D-valine |
|
| NMI | Name: | 3-(1-methyl-1H-indol-3-yl)propanoic acid | Formula: | C12 H13 N O2 | SMILES: | O=C(O)CCc2c1ccccc1n(c2)C | InChi: | InChI=1S/C12H13NO2/c1-13-8-9(6-7-12(14)15)10-4-2-3-5-11(10)13/h2-5,8H,6-7H2,1H3,(H,14,15) | Definition date: | 2014-04-07 | Last modified: | 2024-09-27 | Release date: | 2014-06-18 | Identifier: | 3-(1-methyl-1H-indol-3-yl)propanoic acid |
|
| O2H | Name: | ~{N}-(4,4-dimethyl-2-propyl-3,1-benzoxazin-6-yl)-2-[3-methoxy-5-(7-methoxyquinolin-4-yl)oxy-pyridin-2-yl]ethanamide | Formula: | C31 H32 N4 O5 | SMILES: | CCCC1=Nc2ccc(NC(=O)Cc3ncc(Oc4ccnc5cc(OC)ccc45)cc3OC)cc2C(C)(C)O1 | InChi: | InChI=1S/C31H32N4O5/c1-6-7-30-35-24-11-8-19(14-23(24)31(2,3)40-30)34-29(36)17-26-28(38-5)16-21(18-33-26)39-27-12-13-32-25-15-20(37-4)9-10-22(25)27/h8-16,18H,6-7,17H2,1-5H3,(H,34,36) | Definition date: | 2020-01-21 | Last modified: | 2024-09-27 | Release date: | 2020-05-27 | Identifier: | ~{N}-(4,4-dimethyl-2-propyl-3,1-benzoxazin-6-yl)-2-[3-methoxy-5-(7-methoxyquinolin-4-yl)oxy-pyridin-2-yl]ethanamide |
|
| QXQ | Name: | ~{N}-[3-(7,8-dihydro-5~{H}-[1,3]dioxolo[4,5-g]isoquinolin-6-ylmethyl)phenyl]-2-ethyl-2-methanoyl-butanamide | Formula: | C24 H28 N2 O4 | SMILES: | CCC(CC)(C=O)C(=O)Nc1cccc(CN2CCc3cc4OCOc4cc3C2)c1 | InChi: | InChI=1S/C24H28N2O4/c1-3-24(4-2,15-27)23(28)25-20-7-5-6-17(10-20)13-26-9-8-18-11-21-22(30-16-29-21)12-19(18)14-26/h5-7,10-12,15H,3-4,8-9,13-14,16H2,1-2H3,(H,25,28) | Definition date: | 2020-08-19 | Last modified: | 2024-09-27 | Release date: | 2021-06-30 | Identifier: | ~{N}-[3-(7,8-dihydro-5~{H}-[1,3]dioxolo[4,5-g]isoquinolin-6-ylmethyl)phenyl]-2-ethyl-2-methanoyl-butanamide |
|
| OWN | Name: | methyl 4-(cyclopropylmethyl)-1-prop-2-enoyl-2,3-dihydroquinoxaline-6-carboxylate | Formula: | C17 H20 N2 O3 | SMILES: | COC(=O)c1ccc2N(CCN(CC3CC3)c2c1)C(=O)C=C | InChi: | InChI=1S/C17H20N2O3/c1-3-16(20)19-9-8-18(11-12-4-5-12)15-10-13(17(21)22-2)6-7-14(15)19/h3,6-7,10,12H,1,4-5,8-9,11H2,2H3 | Definition date: | 2020-04-06 | Last modified: | 2024-09-27 | Release date: | 2020-07-22 | Identifier: | methyl 4-(cyclopropylmethyl)-1-prop-2-enoyl-2,3-dihydroquinoxaline-6-carboxylate |
|
| MG2 | Name: | (2S,4R)-N-[1-(iminomethyl)cyclopropyl]-4-[2-(trifluoromethyl)phenyl]sulfonyl-pyrrolidine-2-carboxamide | Formula: | C16 H18 F3 N3 O3 S | SMILES: | O=C(NC1(C=[N@H])CC1)C3NCC(S(=O)(=O)c2ccccc2C(F)(F)F)C3 | InChi: | InChI=1S/C16H18F3N3O3S/c17-16(18,19)11-3-1-2-4-13(11)26(24,25)10-7-12(21-8-10)14(23)22-15(9-20)5-6-15/h1-4,9-10,12,20-21H,5-8H2,(H,22,23)/b20-9+/t10-,12+/m1/s1 | Definition date: | 2013-06-07 | Last modified: | 2024-09-27 | Release date: | 2013-11-27 | Identifier: | (4R)-N-{1-[(E)-iminomethyl]cyclopropyl}-4-{[2-(trifluoromethyl)phenyl]sulfonyl}-L-prolinamide |
|
| PC | Name: | PHOSPHOCHOLINE | Formula: | C5 H15 N O4 P | SMILES: | O=P(O)(O)OCC[N+](C)(C)C | InChi: | InChI=1S/C5H14NO4P/c1-6(2,3)4-5-10-11(7,8)9/h4-5H2,1-3H3,(H-,7,8,9)/p+1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | N,N,N-trimethyl-2-(phosphonooxy)ethanaminium |
|
| PR4 | Name: | 1-[(2R)-2-carboxy-2-hydroxyethyl]-L-proline | Formula: | C8 H13 N O5 | SMILES: | O=C(O)C(O)CN1C(C(=O)O)CCC1 | InChi: | InChI=1S/C8H13NO5/c10-6(8(13)14)4-9-3-1-2-5(9)7(11)12/h5-6,10H,1-4H2,(H,11,12)(H,13,14)/t5-,6+/m0/s1 | Definition date: | 2010-04-02 | Last modified: | 2024-09-27 | Identifier: | 1-[(2R)-2-carboxy-2-hydroxyethyl]-L-proline |
|
| PR7 | Name: | 1-[(2S)-2-carboxy-2-hydroxyethyl]-L-proline | Formula: | C8 H13 N O5 | SMILES: | O=C(O)C(O)CN1C(C(=O)O)CCC1 | InChi: | InChI=1S/C8H13NO5/c10-6(8(13)14)4-9-3-1-2-5(9)7(11)12/h5-6,10H,1-4H2,(H,11,12)(H,13,14)/t5-,6-/m0/s1 | Definition date: | 2010-06-07 | Last modified: | 2024-09-27 | Identifier: | 1-[(2S)-2-carboxy-2-hydroxyethyl]-L-proline |
|
| OHY | Name: | 6-chloro-7-(2-fluoro-6-hydroxyphenyl)-4-(4-propanoylpiperazin-1-yl)-1-[2-(propan-2-yl)phenyl]quinazolin-2(1H)-one | Formula: | C30 H30 Cl F N4 O3 | SMILES: | CC(C)c1c(cccc1)N3c2cc(c(cc2C(=NC3=O)N4CCN(CC4)C(CC)=O)Cl)c5c(F)cccc5O | InChi: | InChI=1S/C30H30ClFN4O3/c1-4-27(38)34-12-14-35(15-13-34)29-21-16-22(31)20(28-23(32)9-7-11-26(28)37)17-25(21)36(30(39)33-29)24-10-6-5-8-19(24)18(2)3/h5-11,16-18,37H,4,12-15H2,1-3H3 | Definition date: | 2019-06-25 | Last modified: | 2024-09-27 | Release date: | 2019-12-25 | Identifier: | 6-chloro-7-(2-fluoro-6-hydroxyphenyl)-4-(4-propanoylpiperazin-1-yl)-1-[2-(propan-2-yl)phenyl]quinazolin-2(1H)-one |
|
| N9R | Name: | ~{N}-[6-(1-methylindol-3-yl)pyrimidin-4-yl]prop-2-enamide | Formula: | C16 H14 N4 O | SMILES: | Cn1cc(c2cc(NC(=O)C=C)ncn2)c3ccccc13 | InChi: | InChI=1S/C16H14N4O/c1-3-16(21)19-15-8-13(17-10-18-15)12-9-20(2)14-7-5-4-6-11(12)14/h3-10H,1H2,2H3,(H,17,18,19,21) | Definition date: | 2023-01-11 | Last modified: | 2024-09-27 | Release date: | 2023-12-13 | Identifier: | ~{N}-[6-(1-methylindol-3-yl)pyrimidin-4-yl]prop-2-enamide |
|
| VUZ | Name: | ~{N}-[3-[[6-chloranyl-2-[(1-ethylpyrazol-4-yl)amino]quinazolin-4-yl]amino]phenyl]prop-2-enamide | Formula: | C22 H20 Cl N7 O | SMILES: | CCn1cc(Nc2nc(Nc3cccc(NC(=O)C=C)c3)c4cc(Cl)ccc4n2)cn1 | InChi: | InChI=1S/C22H20ClN7O/c1-3-20(31)25-15-6-5-7-16(11-15)26-21-18-10-14(23)8-9-19(18)28-22(29-21)27-17-12-24-30(4-2)13-17/h3,5-13H,1,4H2,2H3,(H,25,31)(H2,26,27,28,29) | Definition date: | 2023-08-21 | Last modified: | 2024-09-27 | Release date: | 2024-08-21 | Identifier: | ~{N}-[3-[[6-chloranyl-2-[(1-ethylpyrazol-4-yl)amino]quinazolin-4-yl]amino]phenyl]prop-2-enamide |
|
| MHC | Name: | 3-MERCAPTO-1-(1,3,4,9-TETRAHYDRO-B-CARBOLIN-2-YL)-PROPAN-1-ONE | Formula: | C14 H16 N2 O S | SMILES: | O=C(N3CCc2c1ccccc1nc2C3)CCS | InChi: | InChI=1S/C14H16N2OS/c17-14(6-8-18)16-7-5-11-10-3-1-2-4-12(10)15-13(11)9-16/h1-4,15,18H,5-9H2 | Definition date: | 2002-12-06 | Last modified: | 2024-09-27 | Identifier: | 3-oxo-3-(1,3,4,9-tetrahydro-2H-beta-carbolin-2-yl)propane-1-thiol |
|
| M1N | Name: | (1R)-3-METHYL-1-{[N-(MORPHOLIN-4-YLCARBONYL)-3-(1-NAPHTHYL)-D-ALANYL]AMINO}BUTYLBORONIC ACID | Formula: | C23 H32 B N3 O5 | SMILES: | O=C(NC(C(=O)NC(B(O)O)CC(C)C)Cc2c1ccccc1ccc2)N3CCOCC3 | InChi: | InChI=1S/C23H32BN3O5/c1-16(2)14-21(24(30)31)26-22(28)20(25-23(29)27-10-12-32-13-11-27)15-18-8-5-7-17-6-3-4-9-19(17)18/h3-9,16,20-21,30-31H,10-15H2,1-2H3,(H,25,29)(H,26,28)/t20-,21+/m1/s1 | Synonyms: | N-(4-MORPHOLINE)CARBONYL-B-(1-NAPHTHYL)-L-ALANINE-L-LEUCINE BORONIC ACID | Definition date: | 2006-01-10 | Last modified: | 2024-09-27 | Identifier: | [(1R)-3-methyl-1-({(2R)-2-[(morpholin-4-ylcarbonyl)amino]-3-naphthalen-1-ylpropanoyl}amino)butyl]boronic acid (non-preferred name) |
|
| NAF | Name: | M-(N,N,N-TRIMETHYLAMMONIO)-2,2,2-TRIFLUORO-1,1-DIHYDROXYETHYLBENZENE | Formula: | C11 H15 F3 N O2 | SMILES: | FC(F)(F)C(O)(O)c1cc(ccc1)[N+](C)(C)C | InChi: | InChI=1S/C11H15F3NO2/c1-15(2,3)9-6-4-5-8(7-9)10(16,17)11(12,13)14/h4-7,16-17H,1-3H3/q+1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | N,N,N-trimethyl-3-(2,2,2-trifluoro-1,1-dihydroxyethyl)anilinium |
|
| VVW | Name: | 1-[4-[(1~{R})-1-[3,5-bis(chloranyl)pyridin-4-yl]ethoxy]-5-cyano-pyridin-2-yl]-3-[6-methanoyl-5-[(4-methyl-2-oxidanylidene-piperazin-1-yl)methyl]-3-(2-morpholin-4-ylethoxy)pyridin-2-yl]urea | Formula: | C32 H35 Cl2 N9 O6 | SMILES: | C[CH](Oc1cc(NC(=O)Nc2nc(C=O)c(CN3CCN(C)CC3=O)cc2OCCN4CCOCC4)ncc1C#N)c5c(Cl)cncc5Cl | InChi: | InChI=1S/C32H35Cl2N9O6/c1-20(30-23(33)15-36-16-24(30)34)49-26-12-28(37-14-22(26)13-35)39-32(46)40-31-27(48-10-7-42-5-8-47-9-6-42)11-21(25(19-44)38-31)17-43-4-3-41(2)18-29(43)45/h11-12,14-16,19-20H,3-10,17-18H2,1-2H3,(H2,37,38,39,40,46)/t20-/m1/s1 | Definition date: | 2023-08-22 | Last modified: | 2024-09-27 | Release date: | 2024-07-31 | Identifier: | 1-[4-[(1~{R})-1-[3,5-bis(chloranyl)pyridin-4-yl]ethoxy]-5-cyano-pyridin-2-yl]-3-[6-methanoyl-5-[(4-methyl-2-oxidanylidene-piperazin-1-yl)methyl]-3-(2-morpholin-4-ylethoxy)pyridin-2-yl]urea |
|
| SLH | Name: | (2S)-3-(1H-imidazol-5-yl)-2-({[(3R,4aS,8aR)-2-(N-phenyl-beta-alanyl)decahydroisoquinolin-3-yl]methyl}amino)propanal | Formula: | C25 H35 N5 O2 | SMILES: | C3C1C(CCCC1)CC(CNC(C=O)Cc2ncnc2)N3C(=O)CCNc4ccccc4 | InChi: | InChI=1S/C25H35N5O2/c31-17-23(13-22-14-26-18-29-22)28-15-24-12-19-6-4-5-7-20(19)16-30(24)25(32)10-11-27-21-8-2-1-3-9-21/h1-3,8-9,14,17-20,23-24,27-28H,4-7,10-13,15-16H2,(H,26,29)/t19-,20-,23-,24+/m0/s1 | Definition date: | 2015-07-03 | Last modified: | 2024-09-27 | Release date: | 2016-06-22 | Identifier: | (2S)-3-(1H-imidazol-5-yl)-2-({[(3R,4aS,8aR)-2-(N-phenyl-beta-alanyl)decahydroisoquinolin-3-yl]methyl}amino)propanal |
|
| NB3 | Name: | ~{N}-[(1-methylindazol-3-yl)methyl]propanamide | Formula: | C12 H15 N3 O | SMILES: | CCC(=O)NCc1nn(C)c2ccccc12 | InChi: | InChI=1S/C12H15N3O/c1-3-12(16)13-8-10-9-6-4-5-7-11(9)15(2)14-10/h4-7H,3,8H2,1-2H3,(H,13,16) | Synonyms: | N-[(1-methylindazol-3-yl)methyl]prop-2-enamide (precursor) | Definition date: | 2022-08-16 | Last modified: | 2024-09-27 | Release date: | 2022-09-28 | Identifier: | ~{N}-[(1-methylindazol-3-yl)methyl]propanamide |
|
| OJU | Name: | 2-[[[5-(4-azanyl-2-oxidanylidene-pyrimidin-1-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl]oxy-oxidanyl-phosphoryl]oxyethyl-[3-(2-chloranylethanoylamino)propyl]-dimethyl-azanium | Formula: | C18 H33 Cl N5 O12 P2 | SMILES: | C[N+](C)(CCCNC(=O)CCl)CCO[P](O)(=O)O[P](O)(=O)OCC1OC(C(O)C1O)N2C=CC(=NC2=O)N | InChi: | InChI=1S/C18H32ClN5O12P2/c1-24(2,7-3-5-21-14(25)10-19)8-9-33-37(29,30)36-38(31,32)34-11-12-15(26)16(27)17(35-12)23-6-4-13(20)22-18(23)28/h4,6,12,15-17,26-27H,3,5,7-11H2,1-2H3,(H4-,20,21,22,25,28,29,30,31,32)/p+1 | Synonyms: | Cytidine-diphosphate with a thiol-reactive chloroacetamide (cross-linker) | Definition date: | 2022-09-13 | Last modified: | 2024-09-27 | Release date: | 2023-04-12 | Identifier: | 2-[[[5-(4-azanyl-2-oxidanylidene-pyrimidin-1-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl]oxy-oxidanyl-phosphoryl]oxyethyl-[3-(2-chloranylethanoylamino)propyl]-dimethyl-azanium |
|
| SLR | Name: | (3R,4R)-3-hydroxy-2-[(1S)-1-hydroxy-2-methylpropyl]-4-methyl-5-oxo-D-proline | Formula: | C10 H17 N O5 | SMILES: | O=C1NC(C(=O)O)(C(O)C1C)C(O)C(C)C | InChi: | InChI=1S/C10H17NO5/c1-4(2)6(12)10(9(15)16)7(13)5(3)8(14)11-10/h4-7,12-13H,1-3H3,(H,11,14)(H,15,16)/t5-,6+,7-,10-/m1/s1 | Definition date: | 2008-07-29 | Last modified: | 2024-09-27 | Identifier: | (3R,4R)-3-hydroxy-2-[(1S)-1-hydroxy-2-methylpropyl]-4-methyl-5-oxo-D-proline |
|
| M2S | Name: | 3-{[(R)-methylsulfinyl]methyl}-L-valine | Formula: | C7 H15 N O3 S | SMILES: | O=S(C)CC(C)(C)C(N)C(=O)O | InChi: | InChI=1S/C7H15NO3S/c1-7(2,4-12(3)11)5(8)6(9)10/h5H,4,8H2,1-3H3,(H,9,10)/t5-,12-/m1/s1 | Synonyms: | 3,3-dimethyl-methionine sulfoxide | Definition date: | 2008-06-03 | Last modified: | 2024-09-27 | Identifier: | 3-{[(R)-methylsulfinyl]methyl}-L-valine |
|
| TVA | Name: | N-[(2R,3S)-3-amino-2-hydroxy-4-(thiophen-2-yl)butyl]-L-norvaline | Formula: | C13 H22 N2 O3 S | SMILES: | O=C(O)C(NCC(O)C(N)Cc1sccc1)CCC | InChi: | InChI=1S/C13H22N2O3S/c1-2-4-11(13(17)18)15-8-12(16)10(14)7-9-5-3-6-19-9/h3,5-6,10-12,15-16H,2,4,7-8,14H2,1H3,(H,17,18)/t10-,11-,12+/m0/s1 | Definition date: | 2014-06-24 | Last modified: | 2024-09-27 | Release date: | 2015-07-01 | Identifier: | N-[(2R,3S)-3-amino-2-hydroxy-4-(thiophen-2-yl)butyl]-L-norvaline |
|